BioTime, Inc. (BTX) PT Raised to $6.50 at Ladenburg Thalmann
Tweet Send to a Friend
Ladenburg Thalmann raised its price target on BioTime, Inc. (NYSE: BTX) to $6.50 (from $6.00) while maintaining a Buy rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
